Boryung Corporation (003850.KS)
KRW 10260.0
(-3.39%)
KRW 10260.0
(-3.39%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 151.7 Billion KRW | 60.45% |
| 2022 | 94.55 Billion KRW | -50.03% |
| 2021 | 189.23 Billion KRW | 11.05% |
| 2020 | 170.39 Billion KRW | 134.75% |
| 2019 | 72.58 Billion KRW | 33.7% |
| 2018 | 54.29 Billion KRW | 98.14% |
| 2017 | 27.4 Billion KRW | 0.0% |
| 2016 | - KRW | -100.0% |
| 2015 | 1.24 Billion KRW | -49.65% |
| 2014 | 2.48 Billion KRW | 0.0% |
| 2013 | - KRW | 0.0% |
| 2012 | - KRW | -100.0% |
| 2011 | 100 Million KRW | -66.67% |
| 2010 | 300 Million KRW | -74.79% |
| 2009 | 1.19 Billion KRW | -48.48% |
| 2008 | 2.31 Billion KRW | -32.65% |
| 2007 | 3.43 Billion KRW | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 136.2 Billion KRW | -5.38% |
| 2024 Q1 | 143.95 Billion KRW | -5.11% |
| 2023 Q3 | 157.33 Billion KRW | -4.04% |
| 2023 Q2 | 163.95 Billion KRW | -3.1% |
| 2023 FY | 151.7 Billion KRW | 60.45% |
| 2023 Q1 | 169.2 Billion KRW | 78.96% |
| 2023 Q4 | 151.7 Billion KRW | -3.58% |
| 2022 Q2 | 104.07 Billion KRW | -43.94% |
| 2022 FY | 94.55 Billion KRW | -50.03% |
| 2022 Q4 | 94.55 Billion KRW | -5.72% |
| 2022 Q3 | 100.29 Billion KRW | -3.64% |
| 2022 Q1 | 185.66 Billion KRW | -1.89% |
| 2021 Q2 | 162.7 Billion KRW | -2.27% |
| 2021 Q3 | 158.9 Billion KRW | -2.34% |
| 2021 Q4 | 189.23 Billion KRW | 19.09% |
| 2021 FY | 189.23 Billion KRW | 11.05% |
| 2021 Q1 | 166.49 Billion KRW | -2.29% |
| 2020 Q3 | 173 Billion KRW | 19.04% |
| 2020 FY | 170.39 Billion KRW | 134.75% |
| 2020 Q4 | 170.39 Billion KRW | -1.51% |
| 2020 Q1 | 70.05 Billion KRW | -3.49% |
| 2020 Q2 | 145.33 Billion KRW | 107.47% |
| 2019 FY | 72.58 Billion KRW | 33.7% |
| 2019 Q4 | 72.58 Billion KRW | -3.27% |
| 2019 Q3 | 75.04 Billion KRW | -3.27% |
| 2019 Q2 | 77.57 Billion KRW | -2.89% |
| 2019 Q1 | 79.89 Billion KRW | 47.15% |
| 2018 Q4 | 54.29 Billion KRW | 17.81% |
| 2018 Q2 | 32.4 Billion KRW | 18.25% |
| 2018 FY | 54.29 Billion KRW | 98.14% |
| 2018 Q1 | 27.4 Billion KRW | 0.0% |
| 2018 Q3 | 46.08 Billion KRW | 42.23% |
| 2017 Q1 | - KRW | 0.0% |
| 2017 Q2 | 10 Billion KRW | 0.0% |
| 2017 Q4 | 27.4 Billion KRW | 82.67% |
| 2017 Q3 | 15 Billion KRW | 50.0% |
| 2017 FY | 27.4 Billion KRW | 0.0% |
| 2016 Q4 | - KRW | 0.0% |
| 2016 FY | - KRW | -100.0% |
| 2015 Q2 | 2.49 Billion KRW | -20.0% |
| 2015 FY | 1.24 Billion KRW | -49.65% |
| 2015 Q4 | 1.24 Billion KRW | -33.33% |
| 2015 Q3 | 1.87 Billion KRW | -25.0% |
| 2015 Q1 | 3.12 Billion KRW | 25.88% |
| 2014 Q3 | 1.63 Billion KRW | 6.25% |
| 2014 Q4 | 2.48 Billion KRW | 51.72% |
| 2014 FY | 2.48 Billion KRW | 0.0% |
| 2014 Q1 | - KRW | 0.0% |
| 2014 Q2 | 1.54 Billion KRW | 0.0% |
| 2013 Q3 | - KRW | 0.0% |
| 2013 Q4 | - KRW | 0.0% |
| 2013 FY | - KRW | 0.0% |
| 2013 Q1 | - KRW | 0.0% |
| 2013 Q2 | - KRW | 0.0% |
| 2012 Q2 | - KRW | -100.0% |
| 2012 Q1 | 50 Million KRW | -50.0% |
| 2012 FY | - KRW | -100.0% |
| 2012 Q4 | - KRW | 0.0% |
| 2012 Q3 | - KRW | 0.0% |
| 2011 Q3 | 150 Million KRW | -25.0% |
| 2011 FY | 100 Million KRW | -66.67% |
| 2011 Q1 | 250 Million KRW | -16.67% |
| 2011 Q4 | 100 Million KRW | -33.33% |
| 2011 Q2 | 200 Million KRW | -20.0% |
| 2010 Q1 | 910 Million KRW | -23.53% |
| 2010 FY | 300 Million KRW | -74.79% |
| 2010 Q4 | 300 Million KRW | -14.29% |
| 2010 Q3 | 350 Million KRW | -44.44% |
| 2010 Q2 | 630 Million KRW | -30.77% |
| 2009 Q1 | 2.03 Billion KRW | -12.12% |
| 2009 FY | 1.19 Billion KRW | -48.48% |
| 2009 Q4 | 1.19 Billion KRW | -19.05% |
| 2009 Q3 | 1.47 Billion KRW | -16.0% |
| 2009 Q2 | 1.75 Billion KRW | -13.79% |
| 2008 Q2 | 2.87 Billion KRW | -8.89% |
| 2008 Q4 | 2.31 Billion KRW | -10.81% |
| 2008 Q3 | 2.59 Billion KRW | -9.76% |
| 2008 FY | 2.31 Billion KRW | -32.65% |
| 2008 Q1 | 3.15 Billion KRW | -8.16% |
| 2007 FY | 3.43 Billion KRW | 0.0% |
| 2007 Q1 | 4.22 Billion KRW | 0.0% |
| 2007 Q3 | 3.71 Billion KRW | -7.02% |
| 2007 Q4 | 3.43 Billion KRW | -7.55% |
| 2007 Q2 | 3.99 Billion KRW | -5.45% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Yuyu Pharma, Inc. | 13.64 Billion KRW | -1012.226% |
| Dong-A Socio Holdings Co., Ltd. | 202.06 Billion KRW | 24.92% |
| Ildong Holdings Co., Ltd. | 29.87 Billion KRW | -407.782% |
| HANDOK Inc. | 123.78 Billion KRW | -22.562% |
| Kukje Pharma Co., Ltd. | 475.74 Million KRW | -31788.691% |
| Yuhan Corporation | 60.23 Billion KRW | -151.866% |
| Dong-A ST Co., Ltd. | 161.99 Billion KRW | 6.348% |
| SAMSUNG PHARM. Co., LTD. | 101.81 Million KRW | -148899.649% |
| Hanmi Pharm. Co., Ltd. | 82.02 Billion KRW | -84.946% |
| Hanall Biopharma Co.,Ltd | 590.3 Million KRW | -25599.778% |
| Ilyang Pharmaceutical Co.,Ltd | 6.05 Billion KRW | -2407.573% |
| Dong Sung Bio Pharm.Co.,Ltd. | 18.52 Billion KRW | -719.052% |
| MYUNGMOON Pharm co.,Ltd | 12.58 Billion KRW | -1105.545% |
| Hana Pharm Co., Ltd. | 1.59 Billion KRW | -9388.604% |
| Yuyu Pharma, Inc. | 13.64 Billion KRW | -1012.226% |
| Ilsung Pharmaceuticals Co., Ltd. | 119.67 Million KRW | -126663.184% |
| REYON Pharmaceutical Co., Ltd. | 121 Billion KRW | -25.379% |
| Aprogen pharmaceuticals,Inc. | 32 Billion KRW | -374.088% |
| JW Holdings Corporation | 20.65 Billion KRW | -634.403% |
| Ildong Pharmaceutical Co., Ltd. | 14.82 Billion KRW | -923.314% |
| Chong Kun Dang Pharmaceutical Corp. | 30 Billion KRW | -405.694% |
| JW Pharmaceutical Corporation | 30 Billion KRW | -405.694% |
| Shin Poong Pharm.Co.,Ltd. | 218.96 Million KRW | -69185.466% |
| Hyundai Pharmaceutical Co., Ltd. | 580.64 Million KRW | -26027.472% |
| Samil Pharmaceutical Co.,Ltd | 49.56 Billion KRW | -206.058% |
| Jeil Pharmaceutical Co.,Ltd | 4.45 Billion KRW | -3307.637% |
| Yuyu Pharma, Inc. | 13.64 Billion KRW | -1012.226% |
| Kwang Dong Pharmaceutical Co., Ltd. | 19.02 Billion KRW | -697.303% |
| Daewoong pharmaceutical Co.,Ltd | 93.41 Billion KRW | -62.402% |
| JW Pharmaceutical Corporation | 30 Billion KRW | -405.694% |
| Yuhan Corporation | 60.23 Billion KRW | -151.866% |
| Jeil Pharma Holdings Inc | 10.5 Billion KRW | -1344.84% |
| Yungjin Pharm. Co., Ltd. | 40.37 Billion KRW | -275.722% |
| Suheung Co., Ltd. | 74 Billion KRW | -104.991% |
| JW Pharmaceutical Corporation | 30 Billion KRW | -405.694% |
| Samjin Pharmaceuticals Co., Ltd. | 4.16 Billion KRW | -3541.019% |
| Korea United Pharm Inc. | 10.96 Billion KRW | -1283.883% |
| CKD Bio Corp. | 69.43 Billion KRW | -118.501% |
| Daewon Pharmaceutical Co., Ltd. | 34.57 Billion KRW | -338.783% |
| Dongwha Pharm.Co.,Ltd | 16.12 Billion KRW | -840.669% |
| Whan In Pharm Co.,Ltd. | 307.05 Million KRW | -49307.288% |
| Shin Poong Pharm.Co.,Ltd. | 218.96 Million KRW | -69185.466% |
| Chong Kun Dang Holdings Corp. | 72.11 Billion KRW | -110.377% |
| Bukwang Pharmaceutical Co., Ltd. | 78.52 Billion KRW | -93.197% |
| Ilyang Pharmaceutical Co.,Ltd | 6.05 Billion KRW | -2407.573% |
| JW Lifescience Corporation | 168 Million KRW | -90202.47% |